天津利安隆新材料股份有限公司 证券代码：300596 证券简称：利安隆 公告编号：2025-064 关于参加 2025 年天津辖区上市公司投资者网上 集体接待日暨半年报业绩说明会活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，天津利安隆新材料股份有限公司（以下 简称"公司"）将参加由天津证监局指导、天津上市公司协会及深圳市全景网络 有限公司联合举办的"2025 年天津辖区上市公司投资者网上集体接待日暨半年 报业绩说明会活动"，现将有关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net）；或关注微信公众号（名称：全景财经）；或下载全景路演 APP， 参与本次互动交流。活动时间为 2025 年 9 月 11 日（周四）15:00-17:00。 出席本次活动的有公司董事长、总裁李海平先生，副总裁、董事会秘书谢金 桃女士，财务总监阎文嘉先生，证券事务代表刘佳女士，届时相关人员将在线就 公司 2025 半年度业绩、公司治理、发展战略、经营状况等投资者关心的问题， ...

为进一步加强与投资者的互动交流，天津利安隆新材料股份有限公司（以下 简称"公司"）将参加由天津证监局指导、天津上市公司协会及深圳市全景网络 有限公司联合举办的"2025 年天津辖区上市公司投资者网上集体接待日暨半年 报业绩说明会活动"，现将有关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net）；或关注微信公众号（名称：全景财经）；或下载全景路演 APP， 参与本次互动交流。活动时间为 2025 年 9 月 11 日（周四）15:00-17:00。 出席本次活动的有公司董事长、总裁李海平先生，副总裁、董事会秘书谢金 桃女士，财务总监阎文嘉先生，证券事务代表刘佳女士，届时相关人员将在线就 公司 2025 半年度业绩、公司治理、发展战略、经营状况等投资者关心的问题， 与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告！ 天津利安隆新材料股份有限公司 证券代码：300596 证券简称：利安隆 公告编号：2025-064 天津利安隆新材料股份有限公司 关于参加 2025 年天津辖区上市公司投资者网上 集体接待日暨半年报业绩说明会活动的公告 本公 ...

Core Viewpoint - The article emphasizes the transformative impact of AI on the chemical materials industry, marking a shift from traditional methods to AI-driven approaches that enhance efficiency and innovation in material development [1][6][10]. Group 1: AI and Industry Transformation - AI models and applications have rapidly evolved, leading to a surge of innovative products and marking a technological turning point for the industry [1]. - The integration of AI, embodied intelligence (EI), and big data is accelerating the onset of the Fourth Industrial Revolution in the chemical materials sector [1]. - China is positioned as the largest market and manufacturing base, with abundant application scenarios for AI in material science [1]. Group 2: Collaboration Between Material and AI Companies - Material companies are increasingly collaborating with AI firms to enhance research and development processes [3]. - The shift from traditional experimental methods to AI-enabled approaches is expected to streamline the entire material development chain from research to industrialization [1][6]. Group 3: Expert Insights and Reports - Experts from various institutions shared insights on the opportunities and challenges posed by AI in the chemical materials industry during the 2025 Polymer Industry Annual Conference [4][6][10]. - The reports highlighted the need for companies to overcome technical bottlenecks, data silos, and high costs to fully leverage AI in material development [6][8]. Group 4: AI-Driven Innovations in Material Development - AI is reshaping production optimization and predictive maintenance across seven key areas, contributing to cost reduction and efficiency gains [6]. - The development of high-performance catalytic materials is crucial for sustainable development, with AI facilitating faster and more cost-effective research processes [7]. - AI and automation are being combined to enhance process development, significantly improving research and development efficiency [8]. Group 5: Infrastructure and Case Studies - The construction of "AI + Materials" infrastructure is essential for transitioning to data-driven and model-assisted material development [9]. - Specific case studies demonstrate the successful application of AI in predicting material properties and optimizing formulations, showcasing the potential of AI in polymer research [10]. Group 6: Upcoming Events and Opportunities - The 2025 Polymer Industry Annual Conference will explore new opportunities in emerging industries such as AI, embodied robots, and new energy vehicles [11][12]. - The conference aims to gather industry leaders, experts, and stakeholders to discuss the future of polymer materials and technology [11][12].

Core Viewpoint - The company reported steady revenue growth in its anti-aging additives and improved gross margins in its lubricant additives segment, indicating resilience in a competitive market [1][2]. Financial Performance - In H1 2025, the company achieved revenue of 2.995 billion yuan, a year-on-year increase of 6.21%, and a net profit attributable to shareholders of 241 million yuan, up 9.6% year-on-year, with a gross margin of 21.59%, an increase of 0.18 percentage points [1]. - In Q2 2025, the company recorded revenue of 1.514 billion yuan, a year-on-year increase of 3.29% and a quarter-on-quarter increase of 2.22%; net profit attributable to shareholders was 133 million yuan, up 18.04% year-on-year and 23.59% quarter-on-quarter, with a gross margin of 21.65%, an increase of 0.22 percentage points year-on-year and 0.13 percentage points quarter-on-quarter [1]. Business Segments - In the anti-aging additives segment, the company generated revenue of 2.358 billion yuan, a year-on-year increase of 3.06%, with a shipment volume of 65,500 tons, up 4.30% year-on-year, driven by the development of high-margin products and entry into higher technical barrier downstream fields [2]. - In the lubricant additives segment, the company achieved revenue of 618 million yuan, a year-on-year increase of 18.49%, with a shipment volume of 34,200 tons, up 18.27% year-on-year, supported by increased capacity utilization following the commissioning of the Jinzhou Kangtai Phase II project in 2024 [2]. Market Position and Future Outlook - The company is advancing its domestic production capacity for electronic-grade polyimide through cross-border mergers and acquisitions, with ongoing construction of production bases and R&D centers, aiming for trial production in 2026 [3]. - The company is expected to achieve net profits attributable to shareholders of 505 million yuan, 598 million yuan, and 680 million yuan for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 15.3, 12.9, and 11.3 times [3]. - The company is recognized as a leading player in the domestic anti-aging materials industry, being the only supplier capable of covering a wide range of polymer materials including plastics, rubber, fibers, adhesives, and coatings [3].

Core Insights - Li'anlong (300596) reported a total revenue of 2.995 billion yuan for the first half of 2025, reflecting a year-on-year increase of 6.21% and a net profit attributable to shareholders of 241 million yuan, up 9.6% year-on-year [1] - The company's gross profit margin increased by 0.84% to 21.59%, while the net profit margin rose by 1.67% to 7.81% [1] - The total of selling, administrative, and financial expenses was 216 million yuan, accounting for 7.22% of revenue, a decrease of 3.88% year-on-year [1] Financial Performance - Revenue for Q2 2025 was 1.514 billion yuan, a 3.29% increase year-on-year, with a net profit of 133 million yuan, up 18.04% year-on-year [1] - The company's earnings per share (EPS) increased to 1.05 yuan, a rise of 9.61% year-on-year, while the net asset value per share reached 20.1 yuan, up 8.44% year-on-year [1] - The operating cash flow per share was -0.24 yuan, a significant decrease of 146.28% year-on-year [1] Debt and Cash Flow Analysis - The company’s cash and cash equivalents increased by 74.18% to 1.571 billion yuan, while interest-bearing liabilities rose by 28.42% to 3.378 billion yuan [1] - The cash flow situation is concerning, with cash and cash equivalents to current liabilities at only 54.88% and the average operating cash flow over the past three years to current liabilities at 12.87% [2] - The interest-bearing debt ratio has reached 34.41%, indicating a need for careful monitoring of the company's debt levels [2] Market Position and Analyst Expectations - The company's return on invested capital (ROIC) for the previous year was 6.49%, which is considered average, with a historical median ROIC of 12.83% since its listing [1] - Analysts expect the company's performance in 2025 to reach 500 million yuan, with an average EPS forecast of 2.18 yuan [2] Fund Holdings - The largest fund holding Li'anlong shares is the Agricultural Bank of China Rui Ze Tian Li Bond A, with 129,200 shares newly entered into the top ten holdings [3] - Other funds that have increased their holdings include Qianhai Kaiyuan Xianghe Qian A and Penghua Hongze Mixed A, indicating growing institutional interest in the company [3]

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company's performance in H1 2025 met expectations, with revenue of CNY 2.995 billion, a year-on-year increase of 6.21%, and a net profit attributable to shareholders of CNY 241 million, up 9.60% year-on-year [1][3] - The sales of anti-aging additives showed steady growth, while the profitability of lubricant additives improved significantly [2][3] - The company is solidifying its leading position in the anti-aging agent industry and is actively developing major clients for lubricant additives, with emerging sectors poised for growth [3] Summary by Sections Financial Performance - In Q2 2025, the company achieved revenue of CNY 1.514 billion, a year-on-year increase of 3.29% and a quarter-on-quarter increase of 2.22%. The net profit attributable to shareholders was CNY 133 million, up 18.04% year-on-year and 23.59% quarter-on-quarter [1] - For H1 2025, the anti-aging additives business generated revenue of CNY 2.36 billion, a 3.1% increase year-on-year, with a shipment volume of 65,500 tons, up 4.3% year-on-year [2] - The lubricant additives business reported revenue of CNY 620 million, an 18.5% increase year-on-year, with a shipment volume of 34,200 tons, up 18.3% year-on-year [2] Cost and Profitability - The gross margin for lubricant additives improved by 5.5 percentage points to 13.5% due to increased capacity utilization and collaborative efforts across the supply chain [2] - Sales, management, and R&D expenses increased by 21.9%, 5.0%, and 17.2% respectively, while financial expenses decreased by 110.5% mainly due to currency fluctuations [2] Future Outlook - The company plans to invest in an overseas R&D and production base in Malaysia to enhance its product offerings and expand its international footprint [3] - The company forecasts net profits attributable to shareholders of CNY 503 million, CNY 612 million, and CNY 688 million for 2025, 2026, and 2027 respectively [3][5]

Investment Rating - The report maintains a "Strong Buy" rating for the company [2][5]. Core Views - The company has demonstrated steady performance with a year-on-year revenue increase of 6.21% to CNY 2.995 billion in the first half of 2025, and a net profit growth of 9.60% to CNY 241 million [3]. - The core business segments, including anti-aging additives and lubricant additives, have shown growth in both sales volume and revenue, with lubricant additives experiencing a significant revenue increase of 18.49% [3]. - The company is actively expanding into new business areas, including life sciences and polyimide materials, which are expected to drive future growth [4][5]. Financial Performance Summary - The company achieved a revenue of CNY 5.278 billion in 2023, with a projected growth rate of 9.00% [6]. - The net profit for 2023 is forecasted at CNY 362 million, with a significant increase of 23.90% expected in 2025 [6]. - The earnings per share (EPS) are projected to grow from CNY 1.58 in 2023 to CNY 3.11 by 2027, reflecting a strong upward trend [12]. Business Development - The company is expanding its lubricant additives business, with the second phase of its Jinzhou plant expected to enhance production capacity starting in 2024 [3]. - The life sciences segment is progressing well, with key products entering the market development phase and sales exceeding CNY 1 million monthly [4]. - The company is also investing up to USD 300 million to establish an overseas R&D and production base in Malaysia for high-performance polymer materials [4]. Market Position - The company is recognized as a leading supplier of anti-aging additives in the polymer materials sector, with a strong focus on innovation and customer development [7]. - The total market capitalization of the company is approximately CNY 77.13 billion, indicating a robust market presence [8]. Financial Projections - The company forecasts revenues of CNY 6.379 billion in 2025, with a growth rate of 12.16% [6]. - The projected net profit for 2025 is CNY 528 million, with a consistent growth trajectory expected through 2027 [6].

Core Insights - The company reported a revenue of 2.995 billion yuan for the first half of 2025, representing a year-on-year growth of 6.21%, and a net profit attributable to shareholders of 241 million yuan, up 9.6% year-on-year [1] - In Q2 2025, the company achieved a revenue of 1.514 billion yuan, with a year-on-year increase of 3.29%, and a net profit of 133 million yuan, reflecting an 18.04% year-on-year growth and a 23.59% quarter-on-quarter increase [1] - The company has maintained a compound annual growth rate (CAGR) of 24.59% in revenue over the past 14 years, demonstrating resilience against changes in the international business environment [1] Business Performance - The core business of anti-aging additives generated a revenue of 2.358 billion yuan in the first half of 2025, with a year-on-year growth of 3.06% and a shipment volume of 65,500 tons, up 4.30% year-on-year [2] - The lubricating oil additives segment reported a revenue of 618 million yuan, marking an 18.49% year-on-year increase, with a shipment volume of 34,200 tons, up 18.27% year-on-year [2] - The life sciences division has transitioned its bio-block business from R&D to market development, achieving monthly sales exceeding one million yuan for key products [2] Strategic Initiatives - The company has initiated an overseas capacity expansion plan, establishing a wholly-owned subsidiary in Malaysia to invest up to 300 million USD in a research and production base for high-performance polymer materials and lubricating oil additives [1][2] - The company is actively participating in the formulation of Chinese standards for engine lubricants and collaborating with major international and domestic players in the lubricating oil additives sector [2] - The company is also focusing on cross-border mergers and acquisitions to integrate polyimide technology and establish dual R&D centers and production bases domestically and internationally [2] Financial Projections - The company is projected to achieve revenues of 6.113 billion yuan, 6.603 billion yuan, and 7.593 billion yuan for the years 2025, 2026, and 2027, respectively, with net profits of 495 million yuan, 505 million yuan, and 636 million yuan [3] - The expected earnings per share (EPS) for the same period are 2.16 yuan, 2.20 yuan, and 2.77 yuan, with corresponding price-to-earnings (PE) ratios of 15.6x, 15.3x, and 12.1x [3]

Group 1 - The company reported a revenue of 2.995 billion yuan for H1 2025, representing a year-on-year increase of 6.2%, and a net profit attributable to shareholders of 241 million yuan, up 9.6% year-on-year [1] - In Q2 2025, the company achieved a revenue of 1.514 billion yuan, which is a 3.3% increase year-on-year and a 2.2% increase quarter-on-quarter, with a net profit of 133 million yuan, reflecting an 18% year-on-year growth and a 23.6% quarter-on-quarter increase [1] - The company plans to issue medium-term notes worth 2 billion yuan to repay interest-bearing debts, supplement working capital, and invest in technology innovation and R&D [1] Group 2 - In H1 2025, the company's anti-aging agents and lubricant additives generated revenues of 2.358 billion yuan and 618 million yuan, respectively, with year-on-year growth rates of 3.06% and 18.49% [2] - The gross profit margins for anti-aging agents and lubricant additives were 23.66% and 13.48%, with year-on-year changes of -0.66 and +5.53 percentage points [2] - The life sciences division achieved significant milestones, with key projects reaching stable production and sales, and three products entering the pilot production phase [2] Group 3 - The company's sales gross margin and net margin for H1 2025 were 21.59% and 7.81%, reflecting year-on-year increases of 0.18 and 0.13 percentage points [2] - In Q2 2025, the sales gross margin and net margin were 21.65% and 8.56%, with quarter-on-quarter increases of 0.13 and 1.52 percentage points [2]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][5][14] Core Views - The company reported a revenue of 2.995 billion yuan for the first half of 2025, representing a year-on-year increase of 6.2%, and a net profit attributable to shareholders of 241 million yuan, up 9.6% year-on-year [5][6] - The second quarter of 2025 saw a revenue of 1.514 billion yuan, which is a 3.3% increase year-on-year and a 2.2% increase quarter-on-quarter, with a net profit of 100 million yuan, reflecting an 18% increase year-on-year and a 23.6% increase quarter-on-quarter [5][6] - The company is focused on strengthening its anti-aging agents, lubricant additives, and life sciences sectors while advancing the localization of PI materials to achieve multi-level high-quality development [5][6] Financial Performance - For the first half of 2025, the company's anti-aging agents and lubricant additives generated revenues of 2.358 billion yuan and 618 million yuan, respectively, with year-on-year growth rates of 3.06% and 18.49% [5][9] - The gross margins for anti-aging agents and lubricant additives were 23.66% and 13.48%, with the former experiencing a slight decline of 0.66 percentage points year-on-year, while the latter improved by 5.53 percentage points [5][9] - The company plans to issue 2.92 yuan per share in medium-term notes totaling 2 billion yuan to repay debts, supplement working capital, and invest in technology innovation and R&D projects [5][6] Subsidiary Performance - In the first half of 2025, the subsidiary Jinzhou Kangtai achieved a revenue of 639 million yuan and a net profit of 45.25 million yuan, marking a year-on-year revenue increase of 20.91% and a net profit increase of 160.27% [10] - Other subsidiaries, such as Li'anlong Zhongwei and Li'anlong Kaiya, also reported varying degrees of revenue and profit changes, with Li'anlong Zhuhai showing improvement in profitability [10] Financial Projections - The company forecasts a net profit attributable to shareholders of 516 million yuan, 597 million yuan, and 670 million yuan for the years 2025, 2026, and 2027, respectively, with corresponding EPS of 2.25 yuan, 2.60 yuan, and 2.92 yuan [6][11] - The projected revenue growth rates for the years 2025 to 2027 are 10.1%, 10.3%, and 10.8%, respectively [6][11]